Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in Advanced/Metastatic Liposarcoma
NCT01209598Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2010
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in Liposarcoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2010; status: completed.
02
Drugs
palbociclib
03
Conditions
Liposarcoma
Beyond the preview
Go deeper on NCT01209598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01209598.